Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanna Mangana

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Biologics : Targets & Therapy|August 27, 2009
Long-term pegylated interferon-alpha and its potential in the treatment of melanomaReinhard Dummer, Joanna Mangana
Acta Dermato-Venereologica|October 19, 2019
Hair Depigmentation and Hair Loss in Advanced Melanoma Treated with Combined Immunotherapy and Targeted TherapyFlorentia Dimitriou, Joanna Mangana, Reinhard Dummer
Methods in Molecular Biology (Clifton, N.J.)|February 3, 2019
Serum S100B Levels in MelanomaAnna Lisa Frauchiger, Reinhard Dummer, Joanna Mangana
Current Opinion in Oncology|December 20, 2017
Update on adjuvant melanoma therapyFlorentia Dimitriou, Ralph Peter Braun, Joanna Mangana
Oncotarget|October 24, 2018
A new B-Raf inhibitor combo for advanced melanomaMarjam-Jeanette Barysch, Joanna Mangana, Reinhard Dummer
JAMA Oncology|January 25, 2019
Rapidly Evolving Extensive Fluorodeoxyglucose-Positive Soft-Tissue Activity During Nivolumab TherapyJoanna Mangana, Caroline S Buset, Reinhard Dummer
Therapeutische Umschau. Revue Therapeutique|October 1, 2025
[Escalation and de-escalation of therapy for high-risk melanomas]Reinhard Dummer, Lara Valeska Maul, Egle Ramelyte, et al.
Expert Opinion on Biological Therapy|March 30, 2025
Management of metastatic melanoma with combinations including PD-1 inhibitorsLara Valeska Maul, Egle Ramelyte, Reinhard Dummer, et al.
Cancer Treatment Reviews|March 18, 2020
Targeting complex, adaptive responses in melanoma therapyPhil Cheng, Mitchell Paul Levesque, Reinhard Dummer, et al.
Expert Opinion on Investigational Drugs|March 8, 2012
Sorafenib in melanomaJoanna Mangana, Mitchell P Levesque, Maria B Karpova, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Biologics : Targets & Therapy|August 27, 2009
Long-term pegylated interferon-alpha and its potential in the treatment of melanomaReinhard Dummer, Joanna Mangana
Acta Dermato-Venereologica|October 19, 2019
Hair Depigmentation and Hair Loss in Advanced Melanoma Treated with Combined Immunotherapy and Targeted TherapyFlorentia Dimitriou, Joanna Mangana, Reinhard Dummer
Methods in Molecular Biology (Clifton, N.J.)|February 3, 2019
Serum S100B Levels in MelanomaAnna Lisa Frauchiger, Reinhard Dummer, Joanna Mangana
Current Opinion in Oncology|December 20, 2017
Update on adjuvant melanoma therapyFlorentia Dimitriou, Ralph Peter Braun, Joanna Mangana
Oncotarget|October 24, 2018
A new B-Raf inhibitor combo for advanced melanomaMarjam-Jeanette Barysch, Joanna Mangana, Reinhard Dummer
JAMA Oncology|January 25, 2019
Rapidly Evolving Extensive Fluorodeoxyglucose-Positive Soft-Tissue Activity During Nivolumab TherapyJoanna Mangana, Caroline S Buset, Reinhard Dummer
Therapeutische Umschau. Revue Therapeutique|October 1, 2025
[Escalation and de-escalation of therapy for high-risk melanomas]Reinhard Dummer, Lara Valeska Maul, Egle Ramelyte, et al.
Expert Opinion on Biological Therapy|March 30, 2025
Management of metastatic melanoma with combinations including PD-1 inhibitorsLara Valeska Maul, Egle Ramelyte, Reinhard Dummer, et al.
Cancer Treatment Reviews|March 18, 2020
Targeting complex, adaptive responses in melanoma therapyPhil Cheng, Mitchell Paul Levesque, Reinhard Dummer, et al.
Expert Opinion on Investigational Drugs|March 8, 2012
Sorafenib in melanomaJoanna Mangana, Mitchell P Levesque, Maria B Karpova, et al.
Pageof 9